Oncology & Hematology Coding Alert
Submit Diagnosis Codes For both Secondary and Primary Carcinoma
Question: How can we report the diagnosis for bone metastasis in a patient who has Merkel cell carcinoma?.
Answer: For bone metastasis, you report ICD-9 code 198.5 (Secondary malignant neoplasm of bone and bone marrow). This code applies for metastasis of bone and bone marrow.
ICD-10 options: When reporting bone metastasis in ICD-10, you have specific codes for bone and bone marrow. Make sure your physician documents if the metastases are in the bone or the marrow. Accordingly, you select from the following two codes:
C79.51, Secondary malignant neoplasm of bone
Also, report the primary neoplasm: In addition to the metastasis, you can submit diagnosis codes for Merkel cell carcinoma. According to the site of the Merkel cell carcinoma, you report ICD-9 codes from 209.31 (Merkel cell carcinoma of the face) through 209.36 (Merkel cell carcinoma of other sites).
C79.52, Secondary malignant neoplasm of bone marrow
Oncology & Hematology Coding Alert
- Chemotherapy:
Command These Multiple Substances and Concurrent Hydration Chemotherapy Scenarios With This Advice
Keep count on total hours of infusion and check substances infused. Reporting for multiple infusions [...] - ICD-10:
Boost up Your Breast Cancer Reporting with This Best Advice
Look for both site and side in male breast options. You won’t find a one-to-one [...] - Documentation:
5 Rules You Can Follow to Improve Provider Documentation
Do not assume EMRs are flawless. Documentation compliance is as important as coding accuracy when [...] - You Be the Coder:
Submit Diagnosis Codes For both Secondary and Primary Carcinoma
Question: How can we report the diagnosis for bone metastasis in a patient who has Merkel [...] - Reader Question:
Ascertain Route for Ovarian Cyst Fluid Collection
Question: In a patient suspected to have ovarian tumor, our physician obtained a sample of the [...] - Reader Question:
Distinguish Between Immunotherapy and Chemotherapy
Question: How is immunotherapy different from chemotherapy in treatment of cancer? Ohio Subscriber Answer: Immunotherapy in [...]
